On the afternoon of November 20, 2019, Professor Ding Xianping, director of Institute of genetics, Academy of life sciences, Sichuan University, and other experts visited China Jianlian biomedical technology (Sichuan) Co., Ltd. for guidance. Accompanied by Gao Zhonghua, chairman of China Jianlian biomedical technology (Sichuan) Co., Ltd., Cheng Junjie, technical director of Sichuan Junteng cell gene technology development and application Co., Ltd., Nie Xiaoning, deputy general manager of China Jianlian biomedical technology (Sichuan) Co., Ltd., and Sichuan gaorunde Biotechnology Co., Ltd., visited Sichuan Province human cells and genes Key laboratories such as biological sample bank, cell preparation and storage center, quality testing center, precision medical and third-party clinical medicine laboratory and molecular biology laboratory, humanized therapeutic antibody class I new drug industrialization screening platform, new drug innovation research and development and new drug evaluation center, etc.     

Then Professor Ding Xianping and his leaders had a discussion and exchange with the chairman and senior management of the company in the meeting room of China Health Alliance.

At the forum, first of all, chairman Gao Zhonghua welcomed Professor Ding Xianping and other experts to our company for guidance. Gao Zhonghua, chairman of the company, introduced the company's general situation, core team, core industry and future development direction of the company. After that, he had an in-depth exchange with Professor Ding Xianping on talent introduction and project cooperation. Professor Ding Xianping said that in terms of talent introduction, Deyang is very close to Chengdu with convenient transportation. The company can introduce scientists and highly educated talents nearby. Sichuan University is a place where talents gather. He has trained dozens of doctoral, master's and graduate students. He said that he can introduce highly educated talents to the company and bring in University researchers and college students People oriented and selecting talents nearby play an important role in talent reserve of the company. It is also hoped that Sichuan university can form a long-term cooperation with China Health Alliance Sichuan company, give full play to the talent advantages of the University and the existing platform of the company, establish an enterprise oriented, market-oriented, and focus on scientific and technological innovation, talent introduction, talent training, scientific practice and other aspects. Through in-depth cooperation in cell storage, application and treatment, bioengineering, biotechnology, biopharmaceutical and other fields, it is of great significance to provide strong technical support for the innovation and development of life science, biomedicine, precision medicine and modern clinical medicine. 

Finally, with regard to project cooperation, Professor Ding pointed out: Sichuan University has very mature technology and experience in carrying out third-party clinical examination and precision medicine, and both sides can discuss the cooperation mode. Now that the infrastructure, hardware and software of China Federation of health have been provided, the most important thing is to introduce good projects and excellent teams. Therefore, we are willing to introduce good projects at home and abroad and 1000 experts from the province to China Health Alliance Sichuan Co., Ltd. to work together to achieve win-win results for both sides and make contributions to the development of the biomedical industry in Deyang!